Dr. Ke Li 李科
Chief Physician
Medical Oncology (II), Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionName order: in Chinese the family name comes first (Li Ke). Papers usually list the name as Ke Li or Li K.
Selected publications
32 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Neural Regen Res, 2026 (first author): Neuroinflammation in neurodegenerative diseases: Focusing on the mediation of T lymphocytes. PubMed 40536931
- Front Immunol, 2025 (senior author): Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response. PubMed 41409301
- BMC Cancer, 2024 (senior author): Causal association between skin cancer and immune cells: mendelian randomization (MR) study. PubMed 39020276
- J Transl Med, 2023 (first author): HNRNPA2B1-mediated m(6)A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis. PubMed 37308993
- Thorac Cancer, 2020 (first author): Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p. PubMed 32147945
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion